vaccine, mmr




Concise Prescribing Info
Per 0.5 mL Attenuated Schwarz measles NLT 103 CCID50, RIT 4385 mumps (derived from Jeryl Lynn strain) NLT 103.7 & Wistar RA 27/3 rubella strains of viruses NLT 103 CCID50
Active immunization against measles, mumps & rubella.
Dosage/Direction for Use
Hypersensitivity to neomycin, egg, or after previous administration of measles, mumps &/or rubella vaccines. Severe humoral or cellular (primary or acquired) immunodeficiency eg, symptomatic HIV infection. Pregnancy.
Special Precautions
Postpone vaccination in patients w/ acute severe febrile illness. Syncope (fainting) can occur. Allow evaporation of alcohol & other disinfecting agents from the skin before inj. Limited protection up to 72 hr after exposure to natural measles. Rare anaphylactic event; patients who have experienced anaphylaxis after egg ingestion. History or family history of allergic diseases or convulsions. Thrombocytopenia; immunocompromised patients. Do not administer intravascularly. Do not perform tuberculin testing w/in 4-6 wk after vaccination. Delay vaccination at least 3 mth in patients who have received human γ-globulins or blood transfusion. Avoid pregnancy 1 mth after vaccination. Lactation. Infants <12 mth (except for high-risk cases).
Adverse Reactions
Redness at inj site, fever ≥38°C (rectal) or ≥37.5°C (axillary/oral). Upper resp tract infection; rash; pain & swelling at inj site, fever >39.5°C (rectal) or >39°C (axillary/oral).
Drug Interactions
Other live attenuated vaccines (1 mth apart), human γ-globulins or blood transfusion (at least 3 mth apart).
ATC Classification
J07BD52 - measles, combinations with mumps and rubella, live attenuated ; Belongs to the class of morbilli viral vaccines.
Priorix vaccine (inj)
(0.5 mL vial + diluent (in pre-filled syringe) & 2 sterile needles) 1's (P684.1/vial)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in